The purpose of this study is to evaluate and monitor perioperative management of patients with coronary stents undergoing noncardiac surgery.

Objectives:

• To describe the incidence and severity of adverse cardiovascular events in patients with coronary stents undergoing noncardiac surgery with admission.
• To assess the following-up of the guidelines about the perioperative management of antiplatelet therapy in these patients.
• To assess the relationship between the incidence of cardiac or neurovascular events, as well as bleeding complications with the perioperative management of antiplatelet therapy.
• Number of Participants with Adverse Events as a Measure of Safety

(Not desired)

Inclusion Criteria:

• > 18 years old, with coronary stents
• American Society of Anaesthesia physical status II-V
• noncardiac surgery wiht admission
• informed consent

Exclusion Criteria:

• < 18 years old
• American Society of Anaesthesia physical status I
• ambulatory surgery
• pregnancy
• obstetric anaesthesia
• endoscopic procedures
• cardiac surgery
• not informed consent

Patients with coronary stents undergoing noncardiac surgery with admission between May 2010 and April 2012

20 patienet were not taking previous antiplatelet agents

Perioperative events from surgery to 90 days after

We registered the adverse events from surgery to 90 days after All the events were included in our outcomes definitions

This is a prospective and observational study